Episodes
Tuesday Jun 06, 2023
Testosterone Supplementation in Men: Risks, Benefits & Best Practices
Tuesday Jun 06, 2023
Tuesday Jun 06, 2023
Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Nahid Punjani, M.D., M.P.H
Testosterone has a variety of health benefits. It helps maintain bone density, muscle mass, red blood cell production and sexual function. Testosterone levels in men tend to peak between age 30 to 40 then gradually decline and it’s not unusual to find low testosterone levels in men over the age of 50. It’s also known that in men with hypogonadism, testosterone supplementation can improve libido, bone density and muscle mass. Should we be checking testosterone levels in our middle-age male patients? How do we determine who should receive testosterone supplementation and finally what are the risks of supplementation? In this podcast, these are all questions I’ll be asking our guest, Nahid Punjani, M.D., M.P.H, a urologist at the Mayo Clinic as we discuss “Testosterone Supplementation in Men”.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Friday Mar 31, 2023
Friday Mar 31, 2023
Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Scott M. Cheney, M.D.
Except for skin cancer, prostate cancer is the most common malignancy in males. 1 in 8 men will be diagnosed with prostate cancer during his lifetime, most over the age of 65. If diagnosed early, treatment is quite effective and results in a very favorable survival rate. Several very effective treatment options are now available for patients. In this podcast, we’ll discuss the various treatments and what patients can expect following each option. We’ll review how a post-prostate cancer patient should be followed by their primary care provider and when there might be reason for concern of a recurrence. The guest for this podcast is Scott M. Cheney, M.D., a urologist from the Mayo Clinic in Phoenix, Arizona.
This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Wednesday Mar 29, 2023
Prostate Cancer & Men’s Health Edition | Updates in Advanced Prostate Cancer
Wednesday Mar 29, 2023
Wednesday Mar 29, 2023
Host: Darryl S. Chutka, M.D. [@chutkaMD]
Guest: Alan H. Bryce, M.D.
Prostate cancer is the second most common malignancy in men, second only to skin cancer and due to increased efforts in screening, most prostate cancers are found very early, and these men have an excellent survival rate. Unfortunately, a percentage of men develop an advanced prostate cancer and the disease becomes much more aggressive with significantly lower survival rates. Who’s at risk for advanced prostate cancer? How does the survival rate change with metastatic disease? Finally, what are the various treatment options and how effective are they? In this podcast, we’ll discuss these questions with our guest, Alan H. Bryce, M.D., from the Division of Hematology and Oncology at the Mayo Clinic.
This episode is brought to you by: Astellas Oncology | https://astellasoncology.com/
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Jun 29, 2021
Primary Care Management of the Post-Prostate Cancer Patient
Tuesday Jun 29, 2021
Tuesday Jun 29, 2021
Guest: Matthew K. Tollefson, M.D. (@MattTollefsonMD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Other than skin cancer, prostate cancer is the most common cancer in men in the United States and will affect 1 in every 6 men 65 years and older. Fortunately, when detected early, it is very treatable. Long-term follow-up of patients with treated prostate cancer is usually performed by primary care providers. How often should these patients be seen? How much of an exam is recommended? Which tests should be ordered? When are imaging tests indicated and which studies are the most helpful? This podcast will address these questions and more as we discuss the primary care management of the post-prostate cancer patient with Dr. Matthew Tollefson, a urologist from the Mayo Clinic.
Specific topics discussed:
- Current treatment options for prostate cancer
- Determinants for choosing one of the treatment options for prostate cancer
- When and how often patients should receive follow-up for prostate cancer
- Laboratory tests recommended for the follow-up of prostate cancer patients
- When a detectable PSA is concerning following prostate cancer treatment
- Imaging studies recommended for following prostate cancer patients and when they are indicated
- Treatment options for recurrent prostate cancer
- Future treatment options for prostate cancer which have potential
Additional resources:
- https://www.auanet.org/guidelines/advanced-prostate-cancer
- https://www.mayoclinic.org/diseases-conditions/prostate-cancer/symptoms-causes/syc-20353087
- https://www.mayoclinic.org/medical-professionals/urology
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday May 18, 2021
Identifying Breast Cancer in Men
Tuesday May 18, 2021
Tuesday May 18, 2021
Guest: Kathryn J. Ruddy, M.D. (@KathrynRuddyMD)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Breast cancer in men is very uncommon, about 1/100th as common as in women. It’s expected that this year, just under 3000 men are likely to be diagnosed with it, and just over 500 men will die from breast cancer. Because it’s so uncommon, there are very few good studies which have been completed to educate us about this disease. Kathryn Ruddy, M.D., an oncologist at Mayo Clinic’s Rochester campus joins us to discuss breast cancer in men and what we should do as primary care clinicians to care for our male patients who may be at increased risk to develop it. We’ll cover how breast cancer in males differs from that in females, its risk factors, how it’s diagnosed, and the survival rates of men with a diagnosis of breast cancer.
Specific topics:
- Prevalence of breast cancer
- How most breast cancers in men are found
- The recommended evaluation of a male patient with suspected breast cancer
- Risk factors for breast cancer in men
- Treatment for male breast cancer
- Survival rates for breast cancer in men
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Apr 27, 2021
Fact or Fiction: Erectile Dysfunction Treatments
Tuesday Apr 27, 2021
Tuesday Apr 27, 2021
Guest: Tobias S. Kohler, M.D., M.P.H.
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Erectile dysfunction not only causes lifestyle changes, but it may also be the first symptom of peripheral vascular disease. Since many men are reluctant to mention erectile dysfunction to their healthcare provider, it’s important for us to ask our patients whether it is a problem and be knowledgeable in the appropriate evaluation of patients who have it. This reluctance may cause many to seek out readily available but ineffective treatments from questionable sources, even though there are a variety of proven, effective treatments that can be prescribed. Tobias S. Kohler, M.D., M.P.H., a Mayo Clinic Urologist, joins us to discuss the impact of erectile dysfunction, the currently available effective treatments, as well as the unproven, ineffective products currently being used.
Specific topics discussed:
- The first historical appearance of treatments for erectile dysfunction
- Most common causes of dysfunction
- Appropriate evaluation of patients who present with erectile dysfunction
- Review of the currently available effective treatment options
- Reasons men are reluctant to mention the topic of erectile dysfunction to their provider
- Review of some ineffective treatments currently being promoted
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Feb 05, 2019
Prostate-Specific Antigen (PSA) Testing: A Urologist's Perspective
Tuesday Feb 05, 2019
Tuesday Feb 05, 2019
Guest: Mitchell R. Humphreys, M.D. (@MayoMitch)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Prostate cancer is a very common malignancy in men, second only to skin cancer. Despite the fact that it’s one of the more treatable malignancies, it remains the 2nd leading cause of cancer death in men. When diagnosed early, it has an excellent prognosis. The 5-year survival rate approaches 100% in those with local or regional disease. Although screening for prostate cancer is available, the use of screening tests has been controversial and recommendations regarding its use, confusing. Listen in to get a urologist’s perspective.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.
Tuesday Jan 08, 2019
Tuesday Jan 08, 2019
Guest: Mitchell R. Humphreys, M.D. (@MayoMitch)
Host: Darryl S. Chutka, M.D. (@ChutkaMD)
Our topic for discussion today is benign prostatic hyperplasia, or BPH. By age 60, it’s estimated that 50% of men will have some symptoms of BPH. While BPH is not a life-threatening condition, and only rarely does it result in serious health consequences, it commonly causes symptoms affecting men’s lifestyle. Our guest today is Dr. Mitchell Humphreys, chair of the Department of Urology at Mayo Clinic Arizona and Dean of the Mayo Clinic School of Continuous Professional Development.
Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.